BRPI0914302A2 - intensificador de absorção percutânea e preparação e transdérmica utilizando o mesmo - Google Patents

intensificador de absorção percutânea e preparação e transdérmica utilizando o mesmo

Info

Publication number
BRPI0914302A2
BRPI0914302A2 BRPI0914302A BRPI0914302A BRPI0914302A2 BR PI0914302 A2 BRPI0914302 A2 BR PI0914302A2 BR PI0914302 A BRPI0914302 A BR PI0914302A BR PI0914302 A BRPI0914302 A BR PI0914302A BR PI0914302 A2 BRPI0914302 A2 BR PI0914302A2
Authority
BR
Brazil
Prior art keywords
preparation
same
percutaneous absorption
transdermal enhancer
enhancer
Prior art date
Application number
BRPI0914302A
Other languages
English (en)
Inventor
Naoto Ohtake
Yuuki Koide
Original Assignee
Toa Eiyo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toa Eiyo Ltd filed Critical Toa Eiyo Ltd
Publication of BRPI0914302A2 publication Critical patent/BRPI0914302A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0914302A 2008-06-23 2009-06-22 intensificador de absorção percutânea e preparação e transdérmica utilizando o mesmo BRPI0914302A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008162730 2008-06-23
PCT/JP2009/002837 WO2009157173A1 (ja) 2008-06-23 2009-06-22 経皮吸収促進剤及びこれを用いた経皮投与製剤

Publications (1)

Publication Number Publication Date
BRPI0914302A2 true BRPI0914302A2 (pt) 2015-10-13

Family

ID=41444246

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0914302A BRPI0914302A2 (pt) 2008-06-23 2009-06-22 intensificador de absorção percutânea e preparação e transdérmica utilizando o mesmo

Country Status (9)

Country Link
US (1) US8771724B2 (pt)
EP (1) EP2298352B1 (pt)
JP (2) JP5656221B2 (pt)
KR (1) KR20110036709A (pt)
CN (1) CN102065900B (pt)
BR (1) BRPI0914302A2 (pt)
CA (1) CA2728952C (pt)
RU (1) RU2504363C2 (pt)
WO (1) WO2009157173A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102488900B (zh) * 2011-12-06 2013-09-25 沈阳药科大学 癸酸二乙醇酰胺及类似物的应用
EP2938391B1 (en) * 2012-12-28 2022-07-27 Teikoku Seiyaku Co., Ltd. Extended buprenorphine transdermal delivery compositions
US10292955B2 (en) 2013-04-04 2019-05-21 Hyundai Pharm Co., Ltd. Composition for external use preparation with improved transdermal permeability
CN111195242B (zh) * 2018-11-16 2022-10-25 得生制药股份有限公司 经皮吸收贴片
CA3147431A1 (en) 2019-07-16 2021-01-21 Donaghys Limited Transdermal solvent system and methods of use
CN112933035A (zh) * 2021-01-27 2021-06-11 杭州医学院 一种生物可溶性微针贴片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617316B2 (ja) * 1987-03-06 1994-03-09 積水化学工業株式会社 経皮吸収製剤
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
JPH06219947A (ja) * 1993-01-26 1994-08-09 Kinki Univ 経皮投与製剤
JPH0717851A (ja) 1993-07-02 1995-01-20 Teijin Ltd (メタ)アクリル酸エステル系粘着剤を用いた薬剤含有貼付剤
JPH10182455A (ja) 1996-12-24 1998-07-07 Teisan Seiyaku Kk メラトニン含有貼付剤
FR2768630B1 (fr) 1997-09-22 2000-08-04 Ulice Sa Utilisation d'alkyl monoglucosides en tant que vecteurs moleculaires
US5958447A (en) * 1998-03-17 1999-09-28 Plc Holding, L.L.C. Adhesive matrix type transdermal patch and method of manufacturing same
EP1221315A4 (en) * 1999-10-13 2007-12-12 Senju Pharma Co ADHESIVE OPHTHALMIC PREPARATIONS FOR PERCUTANEOUS SPREADING
AR036237A1 (es) * 2001-07-27 2004-08-25 Bayer Corp Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento
EP1863511A2 (en) 2005-02-23 2007-12-12 UAB Research Foundation Alkyl-glycoside enhanced vaccination
DE102005031482A1 (de) * 2005-07-04 2007-01-18 Henkel Kgaa Hautaufhellende Zusammensetzungen mit verbesserter Wirkung
JP5130203B2 (ja) 2006-04-28 2013-01-30 ライオン株式会社 非水系粘着剤組成物、貼付剤および貼付剤の製造方法
US20070259029A1 (en) 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
US9918934B2 (en) * 2006-12-12 2018-03-20 Edgar Joel Acosta-Zara Linker-based lecithin microemulsion delivery vehicles

Also Published As

Publication number Publication date
CN102065900B (zh) 2013-09-25
CN102065900A (zh) 2011-05-18
JP5656221B2 (ja) 2015-01-21
KR20110036709A (ko) 2011-04-08
JPWO2009157173A1 (ja) 2011-12-08
EP2298352A1 (en) 2011-03-23
CA2728952A1 (en) 2009-12-30
JP2014237728A (ja) 2014-12-18
EP2298352B1 (en) 2015-01-14
RU2504363C2 (ru) 2014-01-20
WO2009157173A1 (ja) 2009-12-30
US8771724B2 (en) 2014-07-08
RU2011102454A (ru) 2012-07-27
EP2298352A4 (en) 2013-12-11
CA2728952C (en) 2015-06-09
US20110104241A1 (en) 2011-05-05
JP5892396B2 (ja) 2016-03-23

Similar Documents

Publication Publication Date Title
BRPI0907453A2 (pt) Compostos, uso e preparação dos mesmos
BRPI0815588A2 (pt) Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano
BRPI0914682A2 (pt) compostos de heteroarila e usos dos mesmos
BRPI0909469A2 (pt) compostos de oximetileno de arila e usos dos mesmos
BRPI0920927A2 (pt) derivados de azaquinolinona e usos dos mesmos
BRPI0923725A2 (pt) "compostos absorventes de uv trifuncionais e uso dos mesmos".
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BRPI0908853A2 (pt) composto oligopeptídicos e seus usos
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
EP1844773A4 (en) PREPARATION FOR PERCUTANEOUS ABSORPTION
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0914536A2 (pt) tiadiazoliloxifenilamidinas e o uso destas como fungicidas
EP1992363A4 (en) PREPARATION FOR TRANSDERMAL ABSORPTION
BRPI0907365A2 (pt) Composição antimicrobiana e uso
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
DK2318378T3 (da) Quinazolin-derivater
BRPI0807905A2 (pt) Composições medicinais aperfeiçoadas compreendendo buprenorfina e naloxona.
DK2325662T3 (da) Multi-indlæsnings- og multi-udlæsningsanalysator
DE502008000740D1 (de) Rollosystem
BRPI0914302A2 (pt) intensificador de absorção percutânea e preparação e transdérmica utilizando o mesmo
PL2235013T3 (pl) Podstawione związki tetrahydroimidazopirydynowe i ich zastosowanie w farmaceutykach
BRPI0907043A2 (pt) Composição, uso do composto, e, composto
BRPI0810047A2 (pt) Compostos e seus usos 707
BRPI0911719A8 (pt) composição coccidiocida e seu uso
BR112012002293A2 (pt) composto, composição farmacêutica, e, uso do composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.